Market Research Future Published a Report named as “Global Imaging Guided Radiotherapy Market”. Report provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
Global Imaging Guided Radiotherapy Market – Key Players
Some of the key players in The Imaging Guided Radiotherapy Market are ViewRay (US), General Electric Company (US), Hitachi, Ltd. (Japan), Siemens AG (Germany), Koninklijke Philips N.V. (Netherland), TOSHIBA CORPORATION (Japan), Varian Medical Systems, Inc. (US), Vision RT Ltd. (UK), Scranton Gillette Communications (US), XinRay Systems (US), and C-RAD (Sweden).
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4276
Global Imaging Guided Radiotherapy Market – Overview
Image Guided Radiotherapy (IGRT), a type of conformal radiotherapy, involves the use of different scans and X-rays to treat an area of cancer. Conformal radiotherapy shapes the radiotherapy beams around the area of the cancerous tissue. It uses X-rays and scans similar to CT scans before and during the radiotherapy treatment. It improves the precision and accuracy of treatment delivery. These therapies are majorly used in the treatment of cancer such as lung cancer, skin cancer, and others.
The Global Imaging Guided Radiotherapy Market is growing exponentially owing to the rising prevalence of cancer and growing demand for advanced therapies are the major factor driving the Imaging Guided Radiotherapy Market. The Global Imaging Guided Radiotherapy Market is expected to grow at a CAGR of 15.8% during the forecasted period.
Global Imaging Guided Radiotherapy Market – Industry Updates
Nov 2017 ViewRay, Inc. has successfully installed the MR-Guided Radiotherapy System in Washington University. This initiative is expected to increase the customer base for ViewRay Inc. and strengthen its position in USA.
Nov 2017 ViewRay, Inc. has successfully installed the MRIdian® Linac in Rigshospitalet and Herlev Hospitals, Denmark. This initiative is expected to strengthen its market in Europe.
Dec 2017 Varian’s Halcyon Treatment System, an image guided radiotherapy has recently received ANVISA Registration from Brazil. With this approval Varian has expanded its reach in Latin America and has the opportunities to increase the overall customer base.
June 2016 Merck to acquire afferent pharmaceuticals in a deal where Merck will acquire a privately held afferent pharmaceutical’s. Afferent pharmaceuticals is a leader in the development of therapeutic, thus this acquisition will benefit Merck and strengthen their therapeutic segment.
Global Imaging Guided Radiotherapy Market – Segmentation
The Global Image Guided Radiotherapy Market is segmented based on types, technology, devices, application, and end users.
Based on types, the market is segmented into soft-tissue imaging, lung MRI, simplifying cardiac MRI, simplifying MRI-conditional implant scans, and silent MRI scanning.
Based on technology, the market is segmented into radiation-based, non-radiation-based systems, and others. Radiation-based system is further segmented into electronic portal imaging devices (EPID), cone beam CT, Fan beam, and others. Non-radiation-based systems are further segmented into ultrasound-based systems, camera-based or optical tracking systems, MRI-guided IGRT, and others.
Based on devices, the market is segmented into X-ray computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography, and others. X-ray computed tomography market is further segmented into digital X-ray, computed tomography (CT), conventional CT, optical tracking, cone beam, MVCT, and others.
Based on end users, the market is segmented in hospitals, smart cancer centers, research institutes, and others.
Global Imaging Guided Radiotherapy Market – Regional Analysis
According to regions, the Global Imaging Guided Radiotherapy Market is dominated by North America. The factor contributing for its growth includes the rising medical tourism and increasing healthcare sector privatization in this region. According to National Institute of Health (NIH) it has been found that in 2016, a projected 1,685,210 new cases of cancer will be detected in the United States and 595,690 individuals will die from the disease which further increases the growth of the market.
Asia-Pacific market is expecting to be the fastest growing market. This high growth is mainly attributed due to increasing R&D funding by the developing countries like China and India for the development of healthcare sector. The various other factors that influence the growth of the market include growing incidence of cancer, aging population, increasing demand for advanced therapies, patent expiry of leading drugs, government initiatives and increasing public awareness about various diseases and treatment options.
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4276
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312